Found: 28
Select item for more details and to access through your institution.
Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The selective mu-opioid receptor antagonist adl5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in mptp-lesioned macaque model of Parkinson's disease.
- Published in:
- Movement Disorders, 2011, v. 26, n. 7, p. 1225, doi. 10.1002/mds.23631
- By:
- Publication type:
- Article
Exosome markers of LRRK2 kinase inhibition.
- Published in:
- NPJ Parkinson's Disease, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41531-020-00138-7
- By:
- Publication type:
- Article
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson's Disease.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 4, p. 841, doi. 10.3390/cells9040841
- By:
- Publication type:
- Article
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time.
- Published in:
- Journal of Neuroscience, 2011, v. 31, n. 19, p. 7190, doi. 10.1523/JNEUROSCI.1171-11.2011
- By:
- Publication type:
- Article
The Toll-Like Receptor-3 Agonist Polyinosinic:Polycytidylic Acid Triggers Nigrostriatal Dopaminergic Degeneration.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 48, p. 16091, doi. 10.1523/JNEUROSCI.2400-10.2010
- By:
- Publication type:
- Article
Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 11, p. 3365, doi. 10.1523/JNEUROSCI.5427-08.2009
- By:
- Publication type:
- Article
Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.
- Published in:
- Journal of Neuroinflammation, 2008, v. 5, p. 1, doi. 10.1186/1742-2094-5-8
- By:
- Publication type:
- Article
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-42847-x
- By:
- Publication type:
- Article
Propagated α-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reply to "Can STN DBS protect both nigral somata and innervation of the striatum?".
- Published in:
- 2017
- By:
- Publication type:
- letter
Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α-synuclein Parkinson's disease rat model.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-0894-0
- By:
- Publication type:
- Article
MOLECULAR NEURODEGENERATION.
- Published in:
- Molecular Neurodegeneration, 2010, v. 5, p. 43, doi. 10.1186/1750-1326-5-43
- By:
- Publication type:
- Article
KP544, a nerve growth factor amplifier: Pharmacokinetics, safety, and efficacy in the ratA preliminary report of part of this work was presented at the Abstracts of the Society for Neuroscience Meeting, New Orleans, LA, 2003.
- Published in:
- Drug Development Research, 2004, v. 62, n. 1, p. 60, doi. 10.1002/ddr.10384
- By:
- Publication type:
- Article
Update on Molecular Imaging in Parkinson’s Disease.
- Published in:
- Neuroscience Bulletin, 2018, v. 34, n. 2, p. 330, doi. 10.1007/s12264-017-0202-6
- By:
- Publication type:
- Article
Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017698
- By:
- Publication type:
- Article
Use of catechol- O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque.
- Published in:
- European Journal of Neuroscience, 2013, v. 37, n. 5, p. 831, doi. 10.1111/ejn.12093
- By:
- Publication type:
- Article
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
- Published in:
- Acta Neuropathologica Communications, 2017, v. 5, p. 1, doi. 10.1186/s40478-017-0416-x
- By:
- Publication type:
- Article
Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.
- Published in:
- Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0375-7
- By:
- Publication type:
- Article
Brain-to-gut trafficking of alpha-synuclein by CD11c<sup>+</sup> cells in a mouse model of Parkinson's disease.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43224-z
- By:
- Publication type:
- Article
Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0167235
- By:
- Publication type:
- Article
An Endogenous Serine/Threonine Protein Phosphatase Inhibitor, G-Substrate, Reduces Vulnerability in Models of Parkinson's Disease.
- Published in:
- Journal of Neuroscience, 2007, v. 27, n. 31, p. 8314, doi. 10.1523/JNEUROSCI.1972-07.2007
- By:
- Publication type:
- Article
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1ΔE9 Transgenic Mice.
- Published in:
- Journal of Neuroscience, 2005, v. 25, n. 44, p. 10220, doi. 10.1523/JNEUROSCI.2773-05.2005
- By:
- Publication type:
- Article
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02759-0
- By:
- Publication type:
- Article
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson's disease mice.
- Published in:
- Journal of Neuroinflammation, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12974-022-02685-7
- By:
- Publication type:
- Article
Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06832-1
- By:
- Publication type:
- Article